Alpha Casts - AI Market Intelligence
A late-stage AstraZeneca trial miss and Apollo’s caution about a slower AI payoff punctuate a day of mixed corporate beats and governance moves. Investors are parsing strong consumer prints in apparel and petrol windfalls against legal and pipeline risks, while debates intensify over whether to lean risk‑on in growth allocations.
400 Episoder
Kommentarer
0Vær den første til å kommentere
Registrer deg nå og bli medlem av Alpha Casts - AI Market Intelligence sitt community!